Answers are grounded in this paper and cite their sources.
Furanosyl analogs of BAU (5-benzylacyclouridine) and BBAU (5-benzyloxybenzylacyclouridine), two potent inhibitors of uridine phosphorylase, were synthesized and evaluated as potential cancer chemotherapeutic agents. The analogs included ribosides, 2,2′-anhydro nucleosides, arabinosides and deoxyribosides. The anhydrouridine intermediates were potent inhibitors of uridine phosphorylase and good potentiators of FdUrd activity in human tumor cells in culture.
No takes yet. Share an insight, caveat, or question.
Chu et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: